ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
-11.33%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$192M
AUM Growth
+$192M
Cap. Flow
-$8.87M
Cap. Flow %
-4.63%
Top 10 Hldgs %
97.01%
Holding
14
New
–
Increased
3
Reduced
–
Closed
1

Top Buys

1
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.8M
2
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
$1.14M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$202K

Top Sells

1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$12M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$82.4M 42.93% 3,835,722 – –
EIDX
2
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$40.4M 21.07% 1,123,630 – –
TECX
3
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$12.6M 6.57% 893,079 +81,081 +10% +$1.14M
OBSV
4
DELISTED
ObsEva SA Ordinary Shares
OBSV
$11.5M 6.02% 1,386,338 – –
MRKR icon
5
Marker Therapeutics
MRKR
$12M
$10.2M 5.33% 2,000,000 – –
SYRE icon
6
Spyre Therapeutics
SYRE
$996M
$9.93M 5.18% 1,291,151 – –
VIRX
7
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$7.27M 3.79% 10,100,000 +2,500,000 +33% +$1.8M
BCEL
8
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$4.75M 2.47% 387,653 – –
NBRV
9
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$3.82M 1.99% 1,910,287 +101,028 +6% +$202K
ZSAN
10
DELISTED
Zosano Pharma Corporation
ZSAN
$3.17M 1.65% 2,028,571 – –
RCUS icon
11
Arcus Biosciences
RCUS
$1.13B
$3.03M 1.58% 333,333 – –
VRNA
12
Verona Pharma
VRNA
$9.16B
$2.03M 1.06% 443,596 – –
ACRS icon
13
Aclaris Therapeutics
ACRS
$209M
$685K 0.36% 634,455 – –
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– – -274,513 Closed -$12M